Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes and myocardial infarction.

M Fisher1

  • 1Royal Alexandra Hospital, Paisley, UK.

Bailliere'S Best Practice & Research. Clinical Endocrinology & Metabolism
|April 13, 2000
PubMed
Summary

Diabetic patients with myocardial infarction (MI) face high mortality. While treatments like statins and blood pressure control improve outcomes, the benefit of strict blood glucose control for preventing heart disease in diabetes remains unclear.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey.

Anaesthesia·1999
Same author

Novel cationic amphiphiles as delivery agents for antisense oligonucleotides.

Nucleic acids research·1999
Same author

Interventional cardiology in people with diabetes.

Diabetic medicine : a journal of the British Diabetic Association·1999
Same author

Neuroprotective effects of a novel broad-spectrum cation channel blocker, LOE 908 MS, on experimental focal ischemia: a multispectral study.

Journal of magnetic resonance imaging : JMRI·1999
Same author

Transforming growth factor-beta mediates astrocyte-specific regulation of brain endothelial anticoagulant factors.

Stroke·1999
Same author

Endothelin-1 enhances plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-dependent pathway.

Arteriosclerosis, thrombosis, and vascular biology·1999

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetology

Background:

  • Myocardial infarction (MI) is a leading cause of death in individuals with diabetes.
  • Diabetic patients experiencing MI often have poor metabolic control, but the necessity of tight glycemic management during and after MI is uncertain.
  • Existing treatments like thrombolysis, aspirin, beta-blockers, and ACE inhibitors can reduce MI case fatality.

Purpose of the Study:

  • To review the impact of various interventions on cardiovascular outcomes in diabetic patients.
  • To assess the role of glycemic control, statin therapy, hypertension management, and hyperlipidemia treatment in preventing heart disease and MI in diabetes.

Main Methods:

  • Review of existing literature and large-scale studies on diabetes management and cardiovascular events.
  • Analysis of data concerning secondary prevention with statins in diabetic patients with prior MI.
  • Evaluation of primary prevention studies examining glycemic control for heart disease and MI in diabetic populations without pre-existing heart disease.

Main Results:

  • Statin treatment effectively reduces cardiovascular end-points in diabetic patients with a history of MI (secondary prevention).
  • Large studies show statistically insignificant reductions in heart disease and MI with improved glycemic control in diabetic patients without existing heart disease (primary prevention).
  • Hypertension management in diabetic individuals prevents cardiovascular end-points.

Conclusions:

  • While secondary prevention with statins and hypertension management are beneficial for diabetic patients, the role of intensive glycemic control in primary prevention of cardiovascular events requires further investigation.
  • Ongoing studies are evaluating the efficacy of hyperlipidemia treatment in reducing heart disease and MI in diabetic populations.

Related Experiment Videos